Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 19, 2019 at 12:42 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,039
    Likes Received:
    3
    via Pfizer (NYSE: PFE) had big expectations for Inlyta when it launched in 2012. Over the past few years, though, it's fallen out of favor as new, more effective treatments set up camp in its neighborhood.

    article source